AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2020
Dec 15, 2020
30237_dirs_2020-12-14_ec6cc1d0-b7c7-4400-aa41-8f2324729a38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-12-01
Reporting Person: Davis Jeffrey A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Common Stock | M | 173 | — | Acquired | 173 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-01 | Restricted Stock Unit | $ | M | 173 | Disposed | Common Stock (173) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vested fully on 12/1/2020.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30